INNOVITA BIOLOGICAL TECHNOLOGYINNOVITA BIOLOGICAL TECHNOLOGYINNOVITA BIOLOGICAL TECHNOLOGY

INNOVITA BIOLOGICAL TECHNOLOGY

No trades
See on Supercharts

688253 fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Innovita Biological Technology Co., Ltd. engages in the research and development, production, and sale of point-of-care testing rapid diagnostic products. It offers five-in-one whole blood respiratory pathogen Immunoglobulin M, three-in-one combined testing of influenza Immunoglobulin M, and five-in-one combined testing of serum respiratory viruses Immunoglobulin M. It also provides prenatal and postnatal care testing products, automatic colloidal gold immunochromatography analyzers, and automatic blood cell analysis pre-sample processors. The company was founded by Xiu Jie Zhang on February 6, 2006 and is headquartered in Beijing, China.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

688253 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company